Mississippi Division Of Medicaid Prior Authorization Lookup
- Mississippi Division Of Medicaid timely filing
- Mississippi Division Of Medicaid coverage criteria
- All Mississippi Division Of Medicaid policy updates
Latest Mississippi Division Of Medicaid prior authorization updates25
- Prior AuthAdministrative/Operational PolicyEff. 2026-08-01Durable Medical Equipment, Medical Appliances and Medical Supplies (DMEPOS)Governs provider participation, enrollment, definitions, reimbursement, warranties, rentals, repairs, and prior authorization requirements for DME, medical appliances, and medical supplies for Mississippi Medicaid beneficiaries; applies to DME suppliers participating in the Mississippi Division of Medicaid program.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-08-01Hearing services: cochlear implants and auditory osseointegrated devices (AODs)Rules governing Medicaid coverage, clinical documentation, and prior authorization requirements for cochlear implants and implantable/non-implantable auditory osseointegrated devices (AODs) for Mississippi Medicaid beneficiaries.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-07-01EBGLYSS (lebrikizumab-lbkz) prior authorization for atopic dermatitisDefines prior authorization requirements for EBGLYSS (lebrikizumab-lbkz) for members (age ≥12 and ≥40 kg) with moderate-to-severe atopic dermatitis requiring Medicaid coverage decisions.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-07-01KATERZIA (amlodipine) — Prior Authorization CriteriaThis policy establishes prior authorization requirements and coverage criteria for KATERZIA (amlodipine) for treatment of hypertension or angina in eligible Mississippi Division of Medicaid members, including pediatric patients age 6 and older.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-07-01MYCAPSSA (octreotide) prior authorization criteriaThis document sets prior authorization (PA) requirements for MYCAPSSA (oral octreotide) for Mississippi Division of Medicaid members, including initial and re-authorization clinical criteria, dosing limits, and prescribing requirements.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-07-01PALSONIFY (paltusotine) prior authorization for acromegalyDefines prior authorization requirements and coverage criteria for PALSONIFY (paltusotine) for treatment of acromegaly in adult Mississippi Medicaid members.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-07-01Prior Authorization Criteria for SDAMLO (amlodipine)This document establishes prior authorization requirements and medical necessity criteria for SDAMLO (amlodipine) for Mississippi Division of Medicaid members, including initial and re-authorization rules and dosing limits.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-07-01Rule 1.9: Genetic TestingDefines Medicaid coverage, clinical criteria, and prior authorization requirements for genetic testing and pregnancy-related genetic screening for beneficiaries of the Mississippi Division of Medicaid.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-07-01SYMBRAVO (meloxicam and rizatriptan) prior authorizationPrior authorization requirements for SYMBRAVO (combination rizatriptan/meloxicam) for acute treatment of migraine in adults under Mississippi Division of Medicaid; describes initial and re-authorization criteria, dosing limits, and documentation expectations.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-01Dupixent (dupilumab) prior authorization criteria for chronic spontaneous urticaria (CSU)Prior authorization criteria for Dupixent (dupilumab) when prescribed for chronic spontaneous urticaria (CSU) for Mississippi Division of Medicaid members; defines requirements for initial and reauthorization approvals and documentation expectations.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-05-01Dupixent (dupilumab) prior authorization for allergic fungal rhinosinusitisDefines prior authorization requirements for Dupixent (dupilumab) when prescribed for allergic fungal rhinosinusitis (AFRS) for Mississippi Division of Medicaid members age 6 and older; applies to providers requesting coverage for this indication.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-05-01JAYTHARI (deflazacort) prior authorization for Duchenne muscular dystrophyDefines prior authorization requirements, dosing, and renewal criteria for JAYTHARI (deflazacort) for treatment of Duchenne muscular dystrophy in beneficiaries age 5 and older under Mississippi Division of Medicaid.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-05-01KYMBEE (deflazacort) prior authorization for Duchenne muscular dystrophyDefines prior authorization requirements for KYMBEE (deflazacort) for treatment of Duchenne muscular dystrophy (DMD) and applies to providers seeking Medicaid coverage from the Mississippi Division of Medicaid.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-05-01STELARA (ustekinumab) Prior Authorization Coverage CriteriaDefines prior authorization requirements for STELARA (ustekinumab) for Mississippi Division of Medicaid members, including initial and re-authorization criteria, dosing reference, and formulation details.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-04-01AMONDYS 45 (casimersen) — Prior Authorization CriteriaDefines prior authorization requirements, initial and re-authorization criteria, dosing, and required documentation for AMONDYS 45 (casimersen) for treatment of Duchenne muscular dystrophy (DMD). Applies to providers submitting PA requests to Mississippi Division of Medicaid.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-04-01JADENU (deferasirox) prior authorization — chronic iron overloadDefines prior authorization requirements and medical necessity criteria for JADENU and JADENU SPRINKLE (deferasirox) for Mississippi Division of Medicaid members; applies to prescribers requesting PA for these products.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-04-01RINVOQ (upadacitinib) prior authorization for atopic dermatitisDefines prior authorization requirements for RINVOQ (upadacitinib) use in moderate to severe atopic dermatitis for Mississippi Division of Medicaid members, including initial and reauthorization criteria and dosing limits.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-02-01Calcitonin Gene-Related Peptides (CGRP) Inhibitors Prior Authorization CriteriaPrior authorization requirements and clinical criteria for calcitonin gene‑related peptide (CGRP) inhibitors used for prevention and acute treatment of migraine and for episodic cluster headache for Mississippi Division of Medicaid members.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-02-01DUVYZAT (givinostat) — Prior Authorization CriteriaPrior authorization requirements and coverage criteria for DUVYZAT (givinostat) for treatment of Duchenne muscular dystrophy (DMD) in patients 6 years and older under Mississippi Division of Medicaid.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-02-01VIVITROL (naltrexone) prior authorization for alcohol dependenceDefines prior authorization requirements for VIVITROL (naltrexone) when used to treat alcohol dependence for Mississippi Division of Medicaid members.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01JASCAYD (nerandomilast) prior authorizationDefines prior authorization requirements for JASCAYD (nerandomilast) for treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis in adults for Mississippi Division of Medicaid members.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01NEMLUVIO (nemolizumab-ilto) prior authorization for atopic dermatitisDefines prior authorization requirements, initial and re-authorization criteria, dosing, and formulation for NEMLUVIO for treatment of moderate-to-severe atopic dermatitis (and prurigo nodularis indication noted) for Mississippi Division of Medicaid members.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01NEMLUVIO (nemolizumab‑ilto) prior authorization for prurigo nodularisStates prior authorization requirements for NEMLUVIO (nemolizumab‑ilto) for treatment of prurigo nodularis (PN) under Mississippi Division of Medicaid; applies to providers requesting PA for this drug.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Prior Authorization Criteria — TONMYA (cyclobenzaprine) sublingual tabletsPrior authorization requirements for TONMYA (cyclobenzaprine sublingual tablets) for treatment of fibromyalgia in adults under Mississippi Division of Medicaid.All Mississippi Division of Medicaid updates
- Prior AuthClinical/Medical PolicyEff. 2025-12-09ONYDA XR (clonidine HCl) prior authorization criteriaDefines prior authorization requirements and coverage criteria for ONYDA XR (clonidine hydrochloride) for treatment of ADHD in pediatric patients, including initial and re-authorization conditions and dosing limits.All Mississippi Division of Medicaid updates
1–25 of 203
1 / 9
Tool Description
Search Mississippi Division Of Medicaidprior authorization policies by drug name, procedure, or policy title. Results include any policy that mentions prior authorization requirements (drug coverage criteria, imaging guidelines, site-of-service rules) not just documents titled “prior authorization.” Every result links to a full policy page with clinical criteria, covered billing codes, documentation requirements, and effective dates.
Filter by payer, specialty, policy type, or effective year; or search directly for a drug (“Wegovy,” “Ozempic”), a procedure (“MRI,” “knee arthroplasty”), or a policy number.
Coverage spans 110+ payers. Jump straight to the busiest prior-auth publishers: UnitedHealthcare, Cigna, Aetna, Anthem, and Centene. You can also browse the full policy updates feed.
Pair a prior-auth search with the billing code lookup to confirm the CPT or J-code on the claim, the payer lookup for plan footprint, and payer profiles for contacts and coverage context.
FAQ
Type a drug name (“Wegovy,” “Ozempic”), a procedure (“MRI,” “knee”), or a policy title into the search bar. Filter results by payer, specialty, policy type, or effective year. Open any result for the full policy page with clinical criteria, covered billing codes, documentation requirements, and effective dates.
Prior Authorization by Payer
Go deeper
Explore OpenPayer Data
Prior auth requirements change all the time. Keep up with every payer policy update in the live policy feed, or browse payers with prior authorization policies.
Toolbox
More OpenPayer Tools
- Billing Code LookupSearch CPT, HCPCS, J-codes, DRG, and dental codes by number or procedure name.
- Healthcare Provider & Facility LookupFind hospitals and healthcare facilities by name, taxonomy, facility type, ownership, or state.
- Health Insurance Payer LookupSearch national health insurance payers and health plans by name and state presence.
- Provider Taxonomy Code LookupSearch NUCC taxonomy codes by code, specialty, grouping, or classification.
- CPT Modifier LookupSearch CPT modifiers by code or name — descriptions, when to use them, and payer policy context.
- Timely Filing LookupFind payer timely filing policies: claim deadlines, corrected claim windows, and appeal timeframes.
- Coverage Criteria LookupSearch payer coverage criteria and medical necessity requirements by drug, procedure, or payer.
- Payer Contact DirectoryClaims, prior authorization, provider services, and appeals contacts for health insurance payers.
Published by
Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.